Trimi vs Telos Rx: Pricing, Shipping, and Medical Oversight

Explore Trimi pricing and plans

Direct comparison table: Trimi vs Telos Rx

Criteria	Trimi	Telos Rx
Starting price (semaglutide)	$99/month (annual plan)	As low as $99/month
Tirzepatide starting price	$125/month (annual plan)	As low as $139/month
Pricing model	Flat pricing that never rises as dose increases	Prices listed “as low as”; your price depends on plan and approval
Shipping	Free overnight, temperature-controlled shipping	Not specified on captured evidence
Clinical approval and oversight	Prescribed by US-licensed clinicians through Arora Health; Medical Director Dr. Sean Arora named	Prescribed after review by a US-licensed provider; provider determines appropriate molecule
Refunds / guarantees	6-month money-back promise; automatic refund if not approved by medical team	Pay $0 if not approved (captured evidence)
Regulatory note	Compounded medications are not FDA-approved	Compounded medications are not FDA-approved

Pricing structure and what each says about cost predictability

Both providers advertise semaglutide from $99 per month, but Trimi presents that price as part of an annual plan where “same price at every dose” and “flat pricing that never rises as your dose increases” are core claims. Telos Rx lists semaglutide “as low as $99 per month” and tirzepatide “as low as $139 per month,” and notes that “your price depends on your plan.” That makes Trimi the clearer choice for a buyer seeking predictable per-month cost as dose changes, while Telos Rx frames its pricing as variable and plan dependent.

Check Telos Rx current pricing

Shipping, fulfillment, and convenience

Trimi specifies free overnight, temperature-controlled shipping and that medications are shipped to your door from named compounding pharmacies. Telos Rx’s captured evidence does not specify shipping details. If overnight shipping and a stated shipping policy matter, Trimi documents free overnight shipping in its evidence.

See Trimi shipping and fulfillment details

Clinical review, molecule selection, and refunds

Both services require review by US-licensed clinicians before prescribing compounded semaglutide or tirzepatide. Telos Rx emphasizes that a US-licensed provider decides which molecule is right for you, noting semaglutide acts on GLP-1 while tirzepatide acts on GLP-1 and GIP. Trimi highlights that prescriptions are reviewed by licensed providers through Arora Health, led by Medical Director Dr. Sean Arora, MD. For refunds, Trimi states a 6-month money-back promise and an automatic refund if not approved by the medical team; Telos Rx indicates you may “pay $0 if not approved” in captured evidence.

Review Telos Rx clinician approval process

Medication types, compounding, and regulatory notes

Both providers offer compounded semaglutide and tirzepatide and explicitly note that compounded medications are not FDA-approved and are prescription-only. Trimi lists named 503A pharmacies that compound medications and says certificates of analysis are available on request. Telos Rx also states compounded medications are not FDA-approved and that treatment is available only when a licensed clinician determines it is medically appropriate.

Final comparison and recommendation

Trimi vs Telos Rx shows three main distinctions: Trimi emphasizes flat pricing that does not rise with dose plus free overnight shipping and a documented 6-month money-back promise; Telos Rx emphasizes per-month pricing presented “as low as” $99 for semaglutide and $139 for tirzepatide and clinician-led molecule selection. Both require US-licensed clinician approval and note compounded medications are not FDA-approved.

Compare Trimi plans now

Choose Trimi if…

you want flat per-month pricing that “never rises as your dose increases,” free overnight temperature-controlled shipping, named compounding pharmacies with certificates of analysis available on request, and a 6-month money-back promise as described in the captured evidence.

Choose Telos Rx if…

you prioritize a clinician-led decision on molecule selection and a pricing presentation that lists semaglutide “as low as” $99/month and tirzepatide “as low as” $139/month, with your final price depending on the plan and clinician approval.